ELIZABETH PENFOLD: Open Payments
NPI 1639354251 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 54 payments from 13 companies in 2025. Trend: 2023 $1,420 · 2024 $1,312 · 2025 $1,229
Food & beverage: $1,129Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $225 |
| Regeneron Healthcare Solutions, Inc. | 9 | $218 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $181 |
| UCB, Inc. | 10 | $181 |
| Janssen Biotech, Inc. | 2 | $125 |
| ABBVIE INC. | 5 | $102 |
| GENZYME CORPORATION | 2 | $67 |
| Botanix SB Inc | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Sandoz Inc. | 1 | $20 |
Products named: Bimzelx, ILUMYA, DUPIXENT, LIBTAYO, COSENTYX, TREMFYA, Rhapsido, BOTOX.
Industry payments across AZ — which companies pay providers there.
